HomeMarket NewsExscientia climbs as Merck KGaA joins AI drug discovery

Exscientia climbs as Merck KGaA joins AI drug discovery

Actionable Trade Ideas

always free

Artificial Intelligence processor unit. Powerful Quantum AI component on PCB motherboard with data transfers.


Exciting news for U.K.-based biotech company Exscientia plc (NASDAQ:EXAI). The company’s stock surged by approximately 20% in pre-market trading on Wednesday following the announcement of a collaboration with German drugmaker Merck KGaA (OTCPK:MKGAF) on AI-driven drug discovery.

Aside from Exscientia (EXAI), several other players in AI-led drug discovery, including Recursion Pharmaceuticals (RXRX), Abcellera Biologics (ABCL), Absci Corporation (ABSI), and Schrodinger (SDGR), should be on investors’ radars.

Swing Trading Ideas and Market Commentary

Need some new swing ideas? Get free weekly swing ideas and market commentary from Jonathan Bernstein here: Swing Trading.

Explore More

Weekly In-Depth Market Analysis and Actionable Trade Ideas

Get institutional-level analysis and trade ideas to take your trading to the next level, sign up for free and become apart of the community.